Levels of GluK5 were only significantly decreased in the latent stage (LP) of epilepsy in the temporal lobe but selective GluK5 antagonists have been reported to prevent convulsive activity and seizures in pilocarpine-induced epilepsy (Smolders et al., 2002). This evidence concerns the gene GRIK5 and epilepsy.